Lantheus Holdings $575 million convertible senior notes offering
The 2.625% convertible notes are due 2027
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
IVERIC bio $324.7 million stock offering
The shares are listed on the Nasdaq Global Select Market
Biodesix $40 million follow-on offering
The shares are listed on the Nasdaq Global Market
RAPT Therapeutics $75 million follow-on offering
The shares are listed on the Nasdaq Global Market
TMS ¥2.9 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Brookdale Senior Living $125 million tangible equity units offering
The offering comprised 2.5 million units
Privia Health $135 million secondary offering
We advised Privia on its debut shelf takedown offering
Tenaya Therapeutics $75 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Natera $400 million follow-on offering
The shares are listed on Nasdaq
Zoetis $1.35 billion senior notes offering
The investment-grade notes are due 2025 and 2032